Dr. Lohoff is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3535 Market St
Philadelphia, PA 19104Phone+1 215-898-4301Fax+1 301-563-9646
Summary
- Dr. Falk W. Lohoff, MD, based in Chevy Chase, MD, specializes in Psychiatry with a focus on Addiction and Psychopharmacology. His educational background includes a residency and fellowship at the University of Pennsylvania Health System after graduating from Humboldt University of Berlin - Charite Faculty of Medicine. He has extensive professional experience, currently serving as Chief of the Section on Clinical Genomics and Experimental Therapeutics at the National Institutes of Health Clinical Center and previously working as an Assistant Professor of Psychiatry at the Hospital of the University of Pennsylvania. Dr. Lohoff is experienced in treating depression, opioid-related disorders, anxiety disorders, and alcoholism. His notable publications include research on biological aging markers, the cardiovascular impact of genetically proxied PCSK9 and HMGCR inhibition, multi-omics analysis of alcohol effects on liver, and a data-driven transcriptomics analysis.
Education & Training
- University of Pennsylvania Health SystemFellowship, Neuropsychopharmacology, 2006 - 2007
- University of Pennsylvania Health SystemResidency, Psychiatry, 2002 - 2006
- Humboldt University of Berlin - Charite Faculty of MedicineClass of 2002
Certifications & Licensure
- FL State Medical License 2023 - 2026
- MD State Medical License 2014 - 2026
- VA State Medical License 2017 - 2026
- DC State Medical License 2017 - 2024
- PA State Medical License 2002 - 2024
- American Board of Psychiatry and Neurology Psychiatry
- American Board of Preventive Medicine Addiction Medicine
Publications & Presentations
PubMed
- Bidirectional Mendelian Randomization Highlights Causal Relationships Between Circulating INHBC and Multiple Cardiometabolic Diseases and Traits.Nellie Y Loh, Daniel B Rosoff, Rebecca Richmond, Raymond Noordam, George Davey Smith
Diabetes. 2024-12-01 - A multi-omics Mendelian randomization study identifies new therapeutic targets for alcohol use disorder and problem drinking.Daniel B Rosoff, Josephin Wagner, Andrew S Bell, Lucas A Mavromatis, Jeesun Jung
Nature Human Behaviour. 2024-11-11 - Multi-Omics Mendelian Randomization Study Investigating the Impact of PCSK9 and HMGCR Inhibition on Type 2 Diabetes Across Five Populations.Daniel B Rosoff, Josephin Wagner, Jeesun Jung, Pal Pacher, Constantinos Christodoulides
Diabetes. 2024-10-17
Press Mentions
- Concerns That Low LDL-C Alters Cognitive Function Challenged in Novel AnalysisAugust 8th, 2022
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: